Pittsburgh biotech firm involved in development of potential COVID-19 treatment

30Apr

Pittsburgh biotech firm involved in development of potential COVID-19 treatment

Portfolio News
CytoAgents, a Pittsburgh biotech firm, and Quotient Sciences, are accelerating development of a COVID-19 treatment. The treatment would focus on what is called a “cytokine storm,” which is an excessive immune response that attacks the body. Read more >>

Share this post

Related Posts

06Mar

Archer Roose’s Bubbly and Malbec Cans Debut in Regal Theatres Nationwide

Archer Roose, the trailblazing purveyor of quality canned wines co-owned by the esteemed actress Elizabeth Banks, is thrilled to announce... read more
15Sep

Corbus Pharmaceuticals Announces Presentation of Three Abstracts and New Lenabasum Data at 2018 ACR Annual Meeting

Corbus Pharmaceuticals Holdings, Inc., a Phase 3 clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to... read more
29Oct

ALung and CytoAgents CEOs talk pandemic’s impact on funding, trials

At 3 Rivers Venture Fair, panel discussion, CEOs address what happened when they changed direction due to Covid-19. Including CytoAgents.... read more
11Apr

Meet Paul Gudonis, CEO of Myomo

Myomo is a medical robotics company that offers expanded mobility for those suffering from neurological disorders and upper-limb paralysis. read more
25Mar

Astrocyte Pharmaceuticals Raises Over $1.3M in Seed Financing Round

Astrocyte Pharmaceuticals Inc., a CNS therapeutics startup, announced today that it has raised approximately $1.36M in a seed financing round.... read more
03Mar

PlaceMe opens the first official co-living building in MA

PlaceMe, Boston’s pioneer co-living company, is launching the first official co-living building in Cambridge, MA. Starting April 1, 2020, the... read more
10Mar

RevBio Awarded Funding to Conduct an In Vivo Bone Experiment on the International Space Station

RevBio, Inc., announced that it has been awarded the opportunity to conduct an in vivo research experiment on the International... read more
22Apr

eSight launches remote benefit for visually impaired employees

Vision enhancement platform eSight has launched a program that allows employees who are visually impaired to become productive in a... read more
26Aug

Framingham’s Rising Star

At 15, highschooler David Zamarin sold his cleaning company to invest in a new product idea leading to the founding... read more
14Oct

With VC Funding Down 53%, Wasabi Technologies Defies The Odds — Raising $250 Million

It’s hard for startups to raise money these days. So when a startup raised a quarter of a billion dollars... read more